People with spinal muscular atrophy (SMA) show high long-term adherence to treatment with Evrysdi (risdiplam), with several patients remaining on the oral therapy after three years, according to a real-world study in Spain. The observational study, which involved adults and children with different SMA types, demonstrated that all patients adhered to treatment — a metric of […] The post SMA patients stick with Evrysdi for years, real-world study finds appeared first on SMA News Today .

Source: https://smanewstoday.com/news/real-world-study-shows-high-adherence-sma-therapy-evrysdi-spain/ (Wed, 20 May 2026)

Ingested by the SMA platform's daily smanewstoday.com RSS pipeline. Cross-linked to our knowledge graph via the news auto-scoring cron.